By Emeritus Professor Shane Darke

Journal articles

Darke S; Peacock A; Duflou JA; Farrell M; Lappin J, 2025, 'Methylphenidate and (lis)dexamfetamine toxicity-related deaths of adults, Australia, 2000–24: analysis of NCIS data', Medical Journal of Australia, 222, pp. 259 - 261, http://dx.doi.org/10.5694/mja2.52604

Darke S; Farrell M; Lappin J, 2025, 'Rare but relevant series', Addiction, 120, pp. 197, http://dx.doi.org/10.1111/add.16697

Darke S; Farrell M; Hall W; Lappin J, 2025, '‘Deaths of despair’: A term that needs to be retired', Addiction, http://dx.doi.org/10.1111/add.70030

Darke S; Duflou J; Chrzanowska A; Farrell M; Lappin J; Peacock A, 2025, 'Changes in the rates and characteristics of gamma hydroxybutyrate (GHB)-related death in Australia, 2001–2023', Drug and Alcohol Review, 44, pp. 366 - 375, http://dx.doi.org/10.1111/dar.13940

Roberts E; Copeland C; Darke S; Farrell M, 2025, 'Characteristics of drug-related deaths where individuals are found submerged in a bath or hot tub in the United Kingdom, 1997–2023', Drug and Alcohol Review, 44, pp. 347 - 354, http://dx.doi.org/10.1111/dar.13950

Zahra E; Darke S; Lappin J; Duflou J; Farrell M, 2024, 'Baclofen-related deaths in Australia 2000–2022', Forensic Science International, 365, http://dx.doi.org/10.1016/j.forsciint.2024.112281

Darke S; Duflou J; Farrell M; Lappin J; Peacock A, 2024, 'Emergence of deaths due to nitazene toxicity in Australia', Drug and Alcohol Review, 43, pp. 2093 - 2094, http://dx.doi.org/10.1111/dar.13920

Darke S; Duflou J; McDonald S; Peacock A; Farrell M; Lappin J, 2024, 'Neuropathology of deaths due to acute alcohol toxicity in Australia, 2011–2022', Drug and Alcohol Dependence, 263, http://dx.doi.org/10.1016/j.drugalcdep.2024.111407

Marel C; Wilson J; Darke S; Ross J; Slade T; Haber PS; Haasnoot K; Visontay R; Keaveny M; Tremonti C; Mills KL; Teesson M, 2024, 'Patterns and Predictors of Heroin Use, Remission, and Psychiatric Health Among People with Heroin Dependence: Key Findings from the 18–20-Year Follow-Up of the Australian Treatment Outcome Study (ATOS)', International Journal of Mental Health and Addiction, 22, pp. 2565 - 2582, http://dx.doi.org/10.1007/s11469-022-01006-6

Darke S; Duflou J; Peacock A; Farrell M; Hall W; Lappin J, 2024, 'A retrospective study of the characteristics and toxicology of cases of lysergic acid diethylamide (LSD)- and psilocybin-related death in Australia', Addiction, 119, pp. 1564 - 1571, http://dx.doi.org/10.1111/add.16518

Darke S; Farrell M; Duflou J; Lappin J, 2024, 'Chronic obstructive pulmonary disease in heroin users: An underappreciated issue with clinical ramifications', Addiction, 119, pp. 1153 - 1155, http://dx.doi.org/10.1111/add.16407

Darke S; Duflou J; Peacock A; Chrzanowska A; Yuen WS; Farrell M; Lappin J, 2024, 'Characteristics, toxicology and major organ pathology of deaths due to acute alcohol toxicity in Australia, 2011–2022', Drug and Alcohol Review, 43, pp. 937 - 945, http://dx.doi.org/10.1111/dar.13817

Hall W; Darke S; Farrell M, 2024, 'Do we need clinical trials of high dose stimulant agonist treatment for stimulant use disorders?', Addiction, 119, pp. 786 - 787, http://dx.doi.org/10.1111/add.16416

Darke S; Duflou J; Peacock A; Farrell M; Lappin J, 2024, 'A descriptive coronial study of heroin toxicity deaths in Australia, 2020–2022: Characteristics, toxicology and survival times', Addiction, 119, pp. 559 - 569, http://dx.doi.org/10.1111/add.16377

Darke S; Duflou J; Peacock A; Farrell M; Lappin J, 2024, 'Differences in heroin overdose deaths in Australia by age, 2020-2022: Disease and estimated survival times', DRUG AND ALCOHOL DEPENDENCE REPORTS, 10, http://dx.doi.org/10.1016/j.dadr.2024.100217

Bharat C; Webb P; Wilkinson Z; McKetin R; Grebely J; Farrell M; Holland A; Hickman M; Tran LT; Clark B; Peacock A; Darke S; Li JH; Degenhardt L, 2023, 'Agreement between self-reported illicit drug use and biological samples: a systematic review and meta-analysis', Addiction, 118, pp. 1624 - 1648, http://dx.doi.org/10.1111/add.16200

Darke S; Farrell M; Lappin J, 2023, 'Overdose and suicide are different phenomena among opioid users that require different clinical management', Australian and New Zealand Journal of Psychiatry, 57, pp. 1095 - 1100, http://dx.doi.org/10.1177/00048674231159298

Lappin JM; Darke S; Farrell M, 2023, 'Psychotogenic potential of prescribed drugs', Australian and New Zealand Journal of Psychiatry, 57, pp. 777 - 779, http://dx.doi.org/10.1177/00048674231174807

Darke S; Duflou J; Peacock A; Farrell M; Lappin J, 2023, 'Characteristics and circumstances of cocaine-related completed suicide in Australia, 2000–2021', Drug and Alcohol Dependence, 244, http://dx.doi.org/10.1016/j.drugalcdep.2023.109803

Darke S; Duflou J; Peacock A; Chrzanowska A; Farrell M; Lappin J, 2023, 'Clinical characteristics of fatal cocaine toxicity in Australia, 2000–2021', Drug and Alcohol Review, 42, pp. 582 - 591, http://dx.doi.org/10.1111/dar.13581

Darke S; Duflou J; Peacock A; Chrzanowska A; Farrell M; Lappin J, 2023, 'Rates, characteristics and toxicology of cocaine-related deaths in Australia, 2000–2021', Addiction, 118, pp. 297 - 306, http://dx.doi.org/10.1111/add.16055

Darke S; Zahra E; Duflou J; Peacock A; Farrell M; Lappin J, 2023, 'Characteristics and circumstances of volatile solvent misuse-related death in Australia, 2000–2021', Clinical Toxicology, 61, pp. 260 - 265, http://dx.doi.org/10.1080/15563650.2023.2184243

Lappin JM; Zahra E; Darke S; Shand F; Sharma S; Draper B; Connors MH; Dear B; Titov N; Campbell G, 2022, 'Presentations to the emergency department with self-harm or suicidal behaviours: A role for digital mental health services?', Journal of Psychiatric Research, 154, pp. 50 - 55, http://dx.doi.org/10.1016/j.jpsychires.2022.07.046

Darke S; Duflou J; Peacock A; Farrell M; Lappin J, 2022, 'Characteristics of fatal tapentadol-related toxicity in Australia', Drug and Alcohol Review, 41, pp. 1071 - 1077, http://dx.doi.org/10.1111/dar.13462

Darke S; Chrzanowska A; Campbell G; Zahra E; Lappin J, 2022, 'Barbiturate-related hospitalisations, drug treatment episodes, and deaths in Australia, 2000‒2018', Medical Journal of Australia, 216, pp. 194 - 198, http://dx.doi.org/10.5694/mja2.51306

Darke S; Peacock A; Duflou J; Farrell M; Lappin J, 2022, 'Characteristics of fatal ‘novel’ synthetic opioid toxicity in Australia', Drug and Alcohol Dependence, 232, http://dx.doi.org/10.1016/j.drugalcdep.2022.109292

Darke S; Peacock A; Duflou J; Farrell M; Lappin J, 2022, 'Characteristics of fatal ‘novel’ benzodiazepine toxicity in Australia', Forensic Science International, 331, http://dx.doi.org/10.1016/j.forsciint.2021.111140

Weatherburn D; Darke S; Zahra E; Farrell M, 2022, 'Who would try (or use more) cannabis if it were legal?', Drug and Alcohol Review, 41, pp. 386 - 395, http://dx.doi.org/10.1111/dar.13360

Darke S; Duflou J; Peacock A; Farrell M; Lappin J, 2022, 'Characteristics of fatal gabapentinoid-related poisoning in Australia, 2000–2020', Clinical Toxicology, 60, pp. 304 - 310, http://dx.doi.org/10.1080/15563650.2021.1965159

Darke S; Banister S; Farrell M; Duflou J; Lappin J, 2021, '‘Synthetic cannabis’: A dangerous misnomer', International Journal of Drug Policy, 98, pp. 103396, http://dx.doi.org/10.1016/j.drugpo.2021.103396

Campbell G; Darke S; Hall W; Lappin J, 2021, 'Increased barbiturate deaths: an unintended consequence of increased publicity for methods of do-it-yourself euthanasia?', Addiction, 116, pp. 3273 - 3275, http://dx.doi.org/10.1111/add.15573

Chrzanowska A; Man N; Darke S; Degenhardt L; Farrell M; Moran L; Peacock A, 2021, 'Unintentional and intentional drug poisoning deaths, Australia, 2012–2016: Drug pattern profile and demographic characteristics', Drug and Alcohol Dependence, 229, http://dx.doi.org/10.1016/j.drugalcdep.2021.109112

Geddes L; Iversen J; Darke S; Dietze P; Maher L, 2021, 'Prevalence and correlates of multiple non-fatal opioid overdoses among people who inject drugs who utilise needle syringe programs in Australia', International Journal of Drug Policy, 96, pp. 103245, http://dx.doi.org/10.1016/j.drugpo.2021.103245

Lappin JM; Darke S, 2021, 'Methamphetamine and heightened risk for early-onset stroke and Parkinson's disease: A review', Experimental Neurology, 343, pp. 113793, http://dx.doi.org/10.1016/j.expneurol.2021.113793

Campbell G; Darke S; Zahra E; Duflou J; Shand F; Lappin J, 2021, 'Trends and characteristics in barbiturate deaths Australia 2000-2019: a national retrospective study', Clinical toxicology (Philadelphia, Pa.), 59, pp. 224 - 230, http://dx.doi.org/10.1080/15563650.2020.1789653

Darke S; Duflou J; Farrell M; Peacock A; Lappin J; Peacock A, 2021, 'Characteristics and circumstances of death related to the self-administration of ketamine', Addiction, 116, pp. 339 - 345, http://dx.doi.org/10.1111/add.15154

Darke S; Duflou J; Larance B; Farrell M; Lappin J, 2021, 'Characteristics and circumstances of death related to buprenorphine toxicity in Australia', Drug and Alcohol Dependence, 218, http://dx.doi.org/10.1016/j.drugalcdep.2020.108360

Darke S; Peacock A; Duflou J; Farrell M; Lappin J; Peacock A, 2020, 'Characteristics and circumstances of death related to gamma hydroxybutyrate (GHB)', Clinical Toxicology, 58, pp. 1028 - 1033, http://dx.doi.org/10.1080/15563650.2020.1726378

Hall W; Darke S; Humphreys K; Marsden J; Neale J; West R, 2020, 'Addiction's policy on publishing effectiveness studies of involuntary treatment of addiction and its variants', Addiction, 115, pp. 1795 - 1796, http://dx.doi.org/10.1111/add.14933

Campbell G; Darke S; Degenhardt L; Townsend H; Carter G; Draper B; Farrell M; Duflou J; Lappin J, 2020, 'Prevalence and Characteristics Associated with Chronic Noncancer Pain in Suicide Decedents: A National Study', Suicide and Life-Threatening Behavior, 50, pp. 778 - 791, http://dx.doi.org/10.1111/sltb.12627

Marel C; Mills K; Visontay R; Wilson J; Darke S; Ross J; Slade T; Haber PS; Haasnoot K; Keaveny M; Tremonti C; Teesson M, 2020, 'Australian treatment outcome study: Protocol for the 18-20-year follow-up of a prospective longitudinal cohort examining the natural history of heroin dependence and associated mortality, psychiatric and physical health, and health service use', BMJ Open, 10, http://dx.doi.org/10.1136/bmjopen-2020-039226

Zahra E; Darke S; Degenhardt L; Campbell G, 2020, 'Rates, characteristics and manner of cannabis-related deaths in Australia 2000–2018', Drug and Alcohol Dependence, 212, http://dx.doi.org/10.1016/j.drugalcdep.2020.108028

Marsden J; Darke S; Hall W; Hickman M; Holmes J; Humphreys K; Neale J; Tucker J; West R, 2020, 'Mitigating and learning from the impact of COVID-19 infection on addictive disorders', Addiction, 115, pp. 1007 - 1010, http://dx.doi.org/10.1111/add.15080

Darke S; Duflou J; Farrell M; Peacock A; Lappin J, 2020, 'Characteristics and circumstances of synthetic cannabinoid-related death', Clinical Toxicology, 58, pp. 368 - 374, http://dx.doi.org/10.1080/15563650.2019.1647344

Darke S; Duflou J; Peacock A; Farrell M; Lappin J, 2019, 'Characteristics and circumstances of death related to new psychoactive stimulants and hallucinogens in Australia', Drug and Alcohol Dependence, 204, http://dx.doi.org/10.1016/j.drugalcdep.2019.107556

Darke S; Farrell M; Duflou J; Larance B; Lappin J, 2019, 'Circumstances of death of opioid users being treated with naltrexone', Addiction, 114, pp. 2000 - 2007, http://dx.doi.org/10.1111/add.14729

Memedovic S; Slade T; Ross J; Darke S; Mills KL; Marel C; Burns L; Lynskey M; Teesson M, 2019, 'Rumination and problematic substance use among individuals with a long-term history of illicit drug use', Drug and Alcohol Dependence, 203, pp. 44 - 50, http://dx.doi.org/10.1016/j.drugalcdep.2019.05.028

Marel C; Mills KL; Slade T; Darke S; Ross J; Teesson M, 2019, 'Modelling Long-Term Joint Trajectories of Heroin Use and Treatment Utilisation: Findings from the Australian Treatment Outcome Study', EClinicalMedicine, 14, pp. 71 - 79, http://dx.doi.org/10.1016/j.eclinm.2019.07.013

Darke S; Duflou J; Kaye S; Farrell M; Lappin J, 2019, 'Psychostimulant Use and Fatal Stroke in Young Adults', Journal of Forensic Sciences, 64, pp. 1421 - 1426, http://dx.doi.org/10.1111/1556-4029.14056

Lappin JM; Darke S, 2019, 'Methamphetamine: An emerging cause of intracerebral hemorrhage in young people', Neurology, 93, pp. 13 - 14, http://dx.doi.org/10.1212/WNL.0000000000007667

Back to profile page